Literature DB >> 645813

Growth regulators in connective tissue. Systemic administration of an aortic extract inhibits tumor growth in mice.

R Eisenstein, B Schumacher, C Meineke, B Matijevitch, K E Kuettner.   

Abstract

A low-molecular-weight fraction prepared from extracts of bovine aorta inhibits the growth of a transplantable mammary tumor and a fibrosarcoma in mice when injected systemically. It also inhibits the growth of the fibrosarcoma in cell culture. The effect on the fibrosarcoma is much more marked than on the mammary tumor. Since the extract is more effective against the fibrosarcoma and is known to inhibit the growth of endothelial cells, it appears that the enhanced effect on this tumor is due to its activity on the endothelial cells of the host and the tumor cells themselves. The material injected is enriched in an antiproteinase we have previously isolated, which has anticollagneolytic activity and is presumed to be the effector molecule.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 645813      PMCID: PMC2018177     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Modification of fibrosarcomas and squamous cell carcinomas of mouse skin using various tissue extracts.

Authors:  S A Winkle; S L Smith
Journal:  Nature       Date:  1976-03-04       Impact factor: 49.962

2.  Collagenase inhibition by cationic proteins derived from cartilage and aorta.

Authors:  K E Kuettner; J Hiti; R Eisenstein; E Harper
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

3.  Specific tumor immunity induced with soluble materials: purification of antigens inducing tumor resistance.

Authors:  N R Pellis; D J Shulan; B D Kahan
Journal:  Biochem Biophys Res Commun       Date:  1976-08-23       Impact factor: 3.575

4.  Effects of protease treatment on growth, morphology, adhesion, and cell surface proteins of secondary chick embryo fibroblasts.

Authors:  B R Zetter; L B Chen; J M Buchanan
Journal:  Cell       Date:  1976-03       Impact factor: 41.582

Review 5.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

6.  [Behavior of Trasylol in the body as a model for the pharmacokinetics of basic polypeptides].

Authors:  E Habermann; D Arndts; M Just; K O Räker; P Török
Journal:  Med Welt       Date:  1973-07-27

7.  Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.

Authors:  N R Pellis; B H Tom; B D Kahan
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

8.  Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection.

Authors:  N R Pellis; B D Kahan
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

9.  Tumor cell collagenase and its inhibition by a cartilage-derived protease inhibitor.

Authors:  K E Kuettner; L Soble; R L Croxen; B Marczynska; J Hiti; E Harper
Journal:  Science       Date:  1977-05-06       Impact factor: 47.728

10.  Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration.

Authors:  L Ossowski; J P Quigley; G M Kellerman; E Reich
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Tumour angiogenesis.

Authors:  F Arnold
Journal:  Ann R Coll Surg Engl       Date:  1985-09       Impact factor: 1.891

Review 2.  Tumor invasion and host extracellular matrix.

Authors:  B U Pauli; D E Schwartz; E J Thonar; K E Kuettner
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

3.  Additive cytotoxicity of adriamycin and a naturally occurring growth inhibitor extracted from bovine aorta.

Authors:  M Haid; J Cohen; G Mazariegos; S Murthy; R Eisenstein; J D Travis
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

4.  Resistance of the embryonic notochord to invasion by malignant neurogenic tumor cells in vitro.

Authors:  W Schroyens; J Camon; L De Ridder
Journal:  Clin Exp Metastasis       Date:  1991 Jul-Aug       Impact factor: 5.150

5.  Angiogenesis inhibitors and their delivery systems.

Authors:  R Langer; J Murray
Journal:  Appl Biochem Biotechnol       Date:  1983-02       Impact factor: 2.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.